OOIR: Observatory of International Research

Papers

(The TQCC of Therapeutic Advances in Endocrinology and Metabolism is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
GLP-1 receptor agonists: an updated review of head-to-head clinical studies	116
Should metformin remain the first-line therapy for treatment of type 2 diabetes?	55
Dipeptidyl peptidase-4 inhibitor use and mortality in COVID-19 patients with diabetes mellitus: an updated systematic review and meta-analysis	33
MAFLD: a multisystem disease	31
The potential role of incretin-based therapies for polycystic ovary syndrome: a narrative review of the current evidence	27
Role of inflammation in diabetic cardiomyopathy	25
Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection	23
Cardiovascular risk in menopausal women and our evolving understanding of menopausal hormone therapy: risks, benefits, and current guidelines for use	23
Insulin resistance in transgender individuals correlates with android fat mass	20
Effect of sodium-glucose cotransporter 2 inhibitor in patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus: a propensity score-matched analysis of real-world data	19
Sodium-glucose cotransporter-2 inhibitors (SGLT2i) in kidney transplant recipients: what is the evidence?	18
Advancements in the treatment of differentiated thyroid cancer	17
Clinical approaches to treat impaired awareness of hypoglycaemia	16
Diabetes clinic reinvented: will technology change the future of diabetes care?	16
The importance of physical activity in management of type 2 diabetes and COVID-19	16
NAFLD in type 1 diabetes: overrated or underappreciated?	15
Current updates on protein as biomarkers for diabetic kidney disease: a systematic review	13
Medullary thyroid carcinoma: recent advances in identification, treatment, and prognosis	13
Therapeutics for type-2 diabetes mellitus: a glance at the recent inclusions and novel agents under development for use in clinical practice	12
Pharmacotherapy to delay the progression of diabetic kidney disease in people with type 2 diabetes: past, present and future	11
Low complication rates of testosterone and estradiol implants for androgen and estrogen replacement therapy in over 1 million procedures	11
Body composition and cardiometabolic health of pediatric patients with X-linked hypophosphatemia (XLH) under burosumab therapy	11
Endotrophin as a novel marker in PCOS and its relation with other adipokines and metabolic parameters: a pilot study	11
In-person and virtual multidisciplinary intensive lifestyle interventions are equally effective in patients with type 2 diabetes and obesity	10
Alteration of serum neuregulin 4 and neuregulin 1 in gestational diabetes mellitus	10

Calcitonin: current concepts and differential diagnosis	9
The potential of GLP-1 receptor agonists in type 2 diabetes and chronic kidney disease: from randomised trials to clinical practice	9
Digital health and diabetes: experience from India	9
Recent advancement in the treatment of boys and adolescents with hypogonadism	9
Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease	9
Bone health in transgender people: a narrative review	8
Diabetic kidney disease: update on clinical management and non-glycaemic effects of newer medications for type 2 diabetes	8
Primary aldosteronism subtyping in the setting of partially successful adrenal vein sampling	8
The effect of specific binding proteins on immunoassay measurements of total and free thyroid hormones and cortisol	8
Prediction of cardiac autonomic neuropathy using a machine learning model in patients with diabetes	8
Sex and ethnic differences in the cardiovascular complications of type 2 diabetes	7
Potential immunological effects of gender-affirming hormone therapy in transgender people – an unexplored area of research	7
Therapeutic approaches for non-alcoholic steatohepatitis	7
Decreased serum C1Q/TNF-related protein 4 concentrations are associated with type 2 diabetes mellitus	7
Update on genetics and epigenetics in metabolic associated fatty liver disease	7